NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025. Read more about NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025.
NCCN Guidelines® Insights: Survivorship, Version 2.2024. Read more about NCCN Guidelines® Insights: Survivorship, Version 2.2024.
Achieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA). Read more about Achieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA).
The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL. Read more about The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL.
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024. Read more about NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study. Read more about Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study.
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024. Read more about NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
